Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda

AIDS

Volumn 11, Issue 13, 1997, Pages 1619-1626

  Ziegler, John L ^a   Newton, Robert ^b   Katongole Mbidde, Edward ^c   Mbulataiye, Sam ^d   De Cock, Kevin ^e   Wabinga, Henry ^d   Mugerwa, Joshua ^d   Katabira, Elly ^d   Jaffe, Harold ^f   Parkin, D Max ^a   Reeves, Gillian ^b   Weiss, Robin ^g   Beral, Valerie ^b  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UGANDA CANCER INSTITUTE   (Uganda)

^d MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^g INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

AIDS; AIDS related neoplasm; HIV; Kaposi's sarcoma; Uganda

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANCER RISK; CANCER STATISTICS; CONTROLLED STUDY; EDUCATION; FEMALE; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; NONHUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; RURAL AREA; SEROPREVALENCE; SEXUAL BEHAVIOR; SOCIOECONOMICS; TRAVEL; UGANDA; URBAN AREA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA; AFRICA SOUTH OF THE SAHARA; BIOLOGY; CASE CONTROL STUDIES; DEVELOPING COUNTRIES; DISEASES; EASTERN AFRICA; ENGLISH SPEAKING AFRICA; HIV INFECTIONS; RESEARCH METHODOLOGY; RESEARCH REPORT; RISK FACTORS; SIGNS AND SYMPTOMS; STUDIES; UGANDA; VIRAL DISEASES;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CASE-CONTROL STUDIES; CHILD; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SARCOMA, KAPOSI; UGANDA;

EID: 9844234805     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199713000-00011     Document Type: Article

References (26)

1. Chang Y, Cesarman E, Pessin MS, et al.: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869.
2. Moore P, Chang Y: Detection of herpesvirus-like DNA in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 1995, 332:1181-1185.
3. Whitby D, Howard MR, Tenant-Howers M, et al.: Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995, 346:799 802.
4. Moore PS, Kingsley I A, Holmberg SD, et al.: Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS 1996, 10:175-180.
5. Gao S-J, Kingsley L, Hoover DR, et al.: Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996, 335:233-241.
6. Boshoff C, Schulz TF, Kennedy M, et al.: Kaposi's sarcoma associated herpesvirus (KSHV) infects endothelial and spindle cells Nature Med 1995, 1:1274-1278.
7. Moore PS, Boshoff C, Weiss RA, Chang Y: Molecular mimicry of human cytokine response pathway genes by KSHV. Science 1996, 274:1739-1744.
8. Lenette ET, Blackbourne DJ, Levy JA: Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996, 348:858-861.
9. Gao S-J, Kingsley L, Li M, et al.: KSHV antibodies among Americans, Italians, and Ugandans with and without Kaposi's sarcoma. Nature Med 1996, 2:925-928.
10. Simpson GR, Schulz TF, Whitby D, et al.: Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996, 348:1133-1138.
11. Wabinga HR, Parkin DM, Wabwire-Mangen F, Mugerwa JW: Cancer in Kampala, Uganda in 1989-91: Changes in incidence in the era of AIDS. Int J Cancer 1993, 54:23 36.
12. Beral V, Peterman TA, Berkelman RL, Jaffe HW: Kaposi's sarcoma among persons with AIDS: a sexually transmitted disease? Lancet 1990, 335:123-128.
13. Beral V, Bull D, Darby S, et al.: Risk of Kaposi's sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS. Lancet 1992, 339:632 635.
14. Desmond-Hellman SD, Mbidde EK, Kizito A, Hellman NS, Ziegler JL: The value of a clinical definition for epidemic KS in predicting HIV seropositivity in Africa. J Acquir Immune Defic Syndr 1991, 4:467-471.
15. Kedes DH, Operkalski O, Busch M, Kohn R, Flood J, Ganem D: The seroepidemiology of human herpesvirus 8 (Kaposi's-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nature Med 1996, 2:918-924.
16. Melbye M, Bayley A, Manuwele JK, et al.: Evidence for heterosexual transmission and clinical manifestations of human immunodeficiency virus infection and related conditions in Lusaka, Zambia. Lancet 1986, ii:1113 1115.
17. Berkley SF, Widy-Wirsky R, Okware S, et al.: Risk factors associated with HIV infection in Uganda J Infect Dis 1989, 160:2 9.
18. Wawer MJ, Sewankambo NK, Berkley S, et al.: Incidence of HIV-1 infection in a rural region of Uganda. BMJ 1994, 308:171 173.
19. Nunn AJ, Kengeya-Kayondo JF, Malamba SS, Seeley JA, Mulder DW. Risk factors for HIV-1 infection in adults in a rural Ugandan community: a population study. AIDS 1994, 8:81-86.
20. Quigley M, Munguli K, Grosskurth H, et al.: Sexual behaviour patterns and other risk factors for HIV infection in rural Tanzania: a case-control study. AIDS 1997, 11:237-248.
21. Obbo C. HIV transmission through social and geographical networks in Uganda. Soc Sci Med 1993, 36:949-955.
22. Henle G, Henle W, Clifford P, et al.: Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst 1969, 43:1147 1457.
23. O'Leary JJ: Seeking the cause of Kaposi's sarcoma. Nature Med 1996, 2:862 863.
24. Taylor JF, Smith PG, Bull D, Pike MC: Kaposi's sarcoma in Uganda: geography and ethnic distribution Br J Cancer 1973, 26:483-495.
25. Ziegler JL: Endemic Kaposi's sarcoma and local volcanic soils. Lancet 1994, 342:1348-1351.
26. McHardy J, Williams EH, Geser A, De-The G, Beth E, Giraldo G: Endemic Kaposi's sarcoma: incidence and risk factors in the West Nile district of Uganda. Int J Cancer 1984, 33:203-212.